Clearstead Advisors’s NRC Health Common Stock NRC Stock Holding History

Clearstead Advisors’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65	Buy	+3	New	+$56	﹤0.01%	3434
2026 Q1	–	Sell	-3	Closed	-$57	–	2654
2025 Q4	$57	Sell	3 -96	-97%	-$1.45K	﹤0.01%	2592
2025 Q3	$1.27K	Buy	99 +64	+183%	+$960	﹤0.01%	2574
2025 Q2	$588	Buy	+35	New	+$473	﹤0.01%	2475

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Clearstead Advisors's NRC Position: Q2 2026 in Review

Clearstead Advisors opened a new position in NRC Health Common Stock (NRC) in Q2 2026: 3 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #3434 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in NRC as recently as Q4 2025.

Clearstead Advisors first reported a position in NRC in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.27K in Q3 2025. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Clearstead Advisors held 3 shares of NRC Health Common Stock worth $65 as of Q2 2026.
NRC Health Common Stock was a new Clearstead Advisors position in Q2 2026.
NRC Health Common Stock made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3434 holding.
Clearstead Advisors first reported a position in NRC Health Common Stock in Q2 2025 and has held it in 4 quarters since.
Clearstead Advisors's NRC Health Common Stock position peaked at $1.27K in Q3 2025.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.